Kristen R Moore1, Meena Tomar2, David M Umbach3, Scott E Gygax2, David W Hilbert2, Donna D Baird1. 1. From the Epidemiology Branch A3-05, National Institute of Environmental Health Sciences, Research Triangle Park, NC. 2. Femeris Women's Health Research Center, Medical Diagnostic Laboratories, A Division of Genesis Biotechnology Group, Hamilton, NJ. 3. Biostatics and Computational Biology Branch A3-05, National Institute of Environmental Health Sciences, Research Triangle Park, NC.
Abstract
BACKGROUND: Reproductive tract infections are hypothesized to influence uterine fibroid development, yet few studies have investigated the common condition of bacterial vaginosis (BV). The literature is currently limited to data using self-report of BV. METHODS: We conducted a nested case-control study of 200 women (100 cases and 100 controls) from a large study of 23- to 35-year-old African American women, 1310 of whom were fibroid-free and prospectively followed up for 5 years to identify incident fibroids with standardized ultrasound examinations. We used quantitative polymerase chain reaction, an objective molecular method, to assess 9 BV-associated and 4 Lactobacillus species from vaginal swab specimens. We used hierarchical logistic regression to compute odds ratios and 95% confidence intervals to examine associations between bacterial species (both individually and grouped as (1) "optimal" Lactobacillus and (2) BV-associated species) with fibroid incidence and number. We also examined vaginal imbalance (quantitatively more BV-associated bacteria than optimal Lactobacilli). RESULTS: Contrary to our hypothesis, we found no increase in fibroid incidence or number among women with more BV-associated bacteria. High imbalance (only BV-associated bacteria, no optimal Lactobacillus bacteria) was actually inversely associated with fibroid incidence (odds ratio, 0.38; 95% confidence interval, 0.17-0.81). CONCLUSIONS: This is the first study of ultrasound-detected incident fibroids and molecular vaginal bacterial assessment. We found no evidence that BV-associated bacteria increase the risk of fibroid incidence or number.
BACKGROUND: Reproductive tract infections are hypothesized to influence uterine fibroid development, yet few studies have investigated the common condition of bacterial vaginosis (BV). The literature is currently limited to data using self-report of BV. METHODS: We conducted a nested case-control study of 200 women (100 cases and 100 controls) from a large study of 23- to 35-year-old African American women, 1310 of whom were fibroid-free and prospectively followed up for 5 years to identify incident fibroids with standardized ultrasound examinations. We used quantitative polymerase chain reaction, an objective molecular method, to assess 9 BV-associated and 4 Lactobacillus species from vaginal swab specimens. We used hierarchical logistic regression to compute odds ratios and 95% confidence intervals to examine associations between bacterial species (both individually and grouped as (1) "optimal" Lactobacillus and (2) BV-associated species) with fibroid incidence and number. We also examined vaginal imbalance (quantitatively more BV-associated bacteria than optimal Lactobacilli). RESULTS: Contrary to our hypothesis, we found no increase in fibroid incidence or number among women with more BV-associated bacteria. High imbalance (only BV-associated bacteria, no optimal Lactobacillus bacteria) was actually inversely associated with fibroid incidence (odds ratio, 0.38; 95% confidence interval, 0.17-0.81). CONCLUSIONS: This is the first study of ultrasound-detected incident fibroids and molecular vaginal bacterial assessment. We found no evidence that BV-associated bacteria increase the risk of fibroid incidence or number.
Authors: Jacques Ravel; Pawel Gajer; Zaid Abdo; G Maria Schneider; Sara S K Koenig; Stacey L McCulle; Shara Karlebach; Reshma Gorle; Jennifer Russell; Carol O Tacket; Rebecca M Brotman; Catherine C Davis; Kevin Ault; Ligia Peralta; Larry J Forney Journal: Proc Natl Acad Sci U S A Date: 2010-06-03 Impact factor: 11.205
Authors: Kristen R Moore; Jennifer S Smith; Stephen R Cole; Dirk P Dittmer; Victor J Schoenbach; Donna D Baird Journal: Am J Epidemiol Date: 2018-02-01 Impact factor: 4.897
Authors: N D Shaw; S S Srouji; C K Welt; K H Cox; J H Fox; J M Adams; P M Sluss; J E Hall Journal: J Clin Endocrinol Metab Date: 2013-11-27 Impact factor: 5.958
Authors: Caroline M Mitchell; Anoria Haick; Evangelyn Nkwopara; Rochelle Garcia; Mara Rendi; Kathy Agnew; David N Fredricks; David Eschenbach Journal: Am J Obstet Gynecol Date: 2014-12-16 Impact factor: 8.661
Authors: Catriona S Bradshaw; Anna N Morton; Jane Hocking; Suzanne M Garland; Margaret B Morris; Lorna M Moss; Leonie B Horvath; Irene Kuzevska; Christopher K Fairley Journal: J Infect Dis Date: 2006-04-26 Impact factor: 5.226
Authors: Jacques Ravel; Rebecca M Brotman; Pawel Gajer; Bing Ma; Melissa Nandy; Douglas W Fadrosh; Joyce Sakamoto; Sara Sk Koenig; Li Fu; Xia Zhou; Roxana J Hickey; Jane R Schwebke; Larry J Forney Journal: Microbiome Date: 2013-12-02 Impact factor: 14.650
Authors: Roberto Romero; Sonia S Hassan; Pawel Gajer; Adi L Tarca; Douglas W Fadrosh; Lorraine Nikita; Marisa Galuppi; Ronald F Lamont; Piya Chaemsaithong; Jezid Miranda; Tinnakorn Chaiworapongsa; Jacques Ravel Journal: Microbiome Date: 2014-02-03 Impact factor: 14.650